# Patent

## Title
Cells for the production of recombinant adenoviruses

## Abstract

A shuttle vector autonomously replicable in bacteria belonging to the genera Gluconobacter and Escherichia is constructed from an endogenous plasmid of Gluconobacter oxydans IF03171 strain, which has a size of about 5.6 kb, or a part thereof, and a plasmid autonomously replicable in bacteria belonging to the genus Escherichia or a part thereof. The present invention provides a novel plasmid useful for gene manipulation of Gluconobacter bacteria, and a shuttle vector utilizing the plasmid.

## Background
1. Field of the Invention

The present invention relates to a plasmid autonomously replicable in a bacterium belonging to the genus Gluconobacter, which is an endogenous plasmid pAG5 of Gluconobacter oxydans IFO3171 strain and has a size of about 5.6 kb, and a shuttle vector which is constructed from the plasmid and a plasmid derived from a bacterium belonging to the genus Escherichia. The shuttle vector is useful for gene manipulation in a bacterium belonging to the genus Gluconobacter.

2. Description of the Related Art

Bacteria belonging to the genus Gluconobacter are industrially useful microorganisms. For example, they produce D-xylulose, xylitol and the like from D-arabitol. Gene manipulation techniques are one of the effective means for breeding of further superior strains from these bacteria. In order to perform such gene manipulation of Gluconobacter bacteria, it is necessary to first develop a host-vector system for an objective bacterium. Further, on the other hand, it will be very convenient if a plasmid vector which is replicable not only in Gluconobacter bacteria but also in other host cells such as those of Escherichia coli (such a vector will be referred to as "shuttle vector" hereinafter) can be obtained, when gene manipulation is performed in Gluconobacter bacteria.

Plasmids derived from Gluconobacter bacteria and vectors utilizing them have so far been reported in Hakkokogaku Kaishi, Vol. 61, pp.15-18, (1983), Japanese Patent Unexamined Publication [KOKAI] No. 59-162883, European Patent Publication EP 0381027, International Patent Publication WO95/23220 and the like. In particular, in Hakkokogaku Kaishi, Vol. 61, pp.15-18 (1983), it has been reported that Gluconobacter oxydans IFO3171 strain harbors one kind of large plasmid (about 26 mega daltons).

The object of the present invention is to provide a novel plasmid useful for gene manipulation of Gluconobacter bacteria and a shuttle vector utilizing such a plasmid.

The present inventors conducted studies in order to achieve the aforementioned object. As a result, they found that Gluconobacter oxydans IFO3171 strain harbors a novel endogenous plasmid, and thus they have accomplished the present invention.

That is, the present invention provides; Gluconobacter, which is an endogenous plasmid of Gluconobacter oxydans IFO3171 strain and has a size of about 5.6 kb or a derivative thereof; in SEQ ID NO: 1; the genus Gluconobacter and a bacterium belonging to the genus Escherichia, which is constructed from a plasmid of the above item (1) or (2) or a part thereof and a plasmid autonomously replicable in a bacterium belonging to the genus Escherichia or a part thereof; autonomously replicable in a bacterium belonging to the genus Escherichia is pUC18; and

According to the present invention, there are provided a novel plasmid derived from Gluconobacter bacteria, and a shuttle vector utilizing the plasmid. The shuttle vector can autonomously replicate in cells of Gluconobacter bacteria and Escherichia coli, and therefore it is useful for gene manipulation of vector DNA, and gene transfer into Gluconobacter bacteria.

FIG. 1 shows the restriction map of the plasmid pAG5. The relative positions of several restriction sites are indicated by nucleotide number;

FIG. 2 shows the outline of the construction of the shuttle vectors pSG8 and pSG6.

Hereinafter, the present invention will be explained in detail.

The novel plasmid of the present invention can be prepared from Gluconobacter oxydans IFO3171 strain. The IFO3171 strain can be obtained by any one from the Institute for Fermentation, Osaka (Postal code: 532-8686, 17-85, Juso-honmachi, 2-chome, Yodogawa-ku, Osaka, Japan).

The plasmid of the present invention can be obtained by culturing the IFO3171 strain inamedium such as YPG medium, and preparing a DNA fraction of cytoplasm from the obtained cells by a usual method for preparing a plasmid DNA from cells, for example, the alkali lysis method (Nucleic Acids Res., 7, 1513 (1979)). Further, the DNA fraction may be purified by EtBr-CsCl equilibrium density-gradient centrifugation method, agarose gel electrophoresis and the like.

The plasmid of the present invention obtained in the examples described hereinafter in such a manner as mentioned above had a size of about 5.6 kb, and designated as pAG5. The pAG5 is a novel plasmid which distinctly differs in its size from the plasmid derived from the Gluconobacter oxydans IFO3171 strain (about 26 mega daltons) reported in Hakkokogaku Kaishi, Vol. 61, pp.15-18 (1983). The restriction map of pAG5 is shown in FIG. 1, and its nucleotide sequence is shown in SEQ ID NO: 1 of Sequence Listing. The nucleotide sequence shown in SEQ ID NO: 1 is represented from the restriction enzyme HindIII recognition site of pAG5 at the 5' end.

The plasmid of the present invention include, in addition to one having the nucleotide sequence shown in SEQ ID NO: 1, a derivative thereof autonomously replicable in Gluconobacter bacteria. Such a derivative may be one corresponding to pAG5 of which portion other than the region responsible for the replication is removed therefrom, or one corresponding to pAG5 of which part is inserted with another DNA sequence.

By ligating pAG5 to a plasmid autonomously replicable in bacterium other than Gluconobacter bacteria, a shuttle vector autonomously replicable in such bacteria can be obtained. As the bacteria other than Gluconobacter bacteria, a bacterium belonging to the genus Escherichia, specifically, Escherichia coli, and the like can be mentioned.

For the construction of the shuttle vector, the whole pAG5 or a part thereof may be used. When a part thereof is used, such a part must contain the region responsible for the replication of pAG5, but a region unnecessary for the replication may be excluded. The region required for the replication can be determined by ligating a part obtained by digesting pAG5 with a restriction enzyme to a plasmid autonomously replicable in Escherichia coli, transforming Gluconobacter oxydans with the obtained recombinant plasmid, and determining if the recombinant plasmid is harbored by the transformant. As an example of the partial fragment of pAG5 that has such a region, there may be exemplified a longer fragment between the two fragments obtained by digesting pAG5 with HindIII and EcoRI.

The plasmid autonomously replicable in Escherichia coli is not particularly limited, and examples thereof include plasmid vectors usually used for the gene manipulation utilizing Escherichia coli. Specifically, there can be mentioned pUC18, pUC19, pBR322, pHSG299, pHSG298, pHSG399, pHSG398, RSF1010, pMW119, pMW118, pMW219, pMW218 and the like. As also for these plasmids, whole plasmid or a part thereof may be used. When a part thereof is used, such a part must contain the region concerning the replication of pAG5, but a region unnecessary for the replication may be excluded. As for many of the usually used vectors for Escherichia coli, the regions required for the replication or unnecessary regions have been well known.

The shuttle vector of the present invention preferably contains a marker gene such as a drug resistance gene. As such a drug resistance gene, an ampicillin resistance gene, chloramphenicol resistance gene and the like can be mentioned. These drug resistance genes are contained in the usually used vectors for Escherichia coli, and they can be used as they are for the construction of the shuttle vector together with the region required for the replication. For example, pUC18 has an ampicillin resistance gene.

Further, the shuttle vector of the present invention desirably has a cloning site, preferably a multi-cloning site. Many of the plasmid vectors for Escherichia coli mentioned above have a multi-cloning site, and they can be used as they are for the shuttle vector of the present invention.

As examples of the shuttle vector of the present invention, pSG8 and pSG6 can be mentioned. pSG8 can be obtained by ligating pAG5 digested with restriction enzyme HindIII, and pUC18 digested with the same restriction enzyme HindIII. pSG6 can be obtained by ligating a longer fragment between the fragments obtained by digesting pAG5 with HindIII and EcoRI, and a longer fragment between the fragments obtained by digesting pUC18 with HindIII and EcoRI. These shuttle vectors are autonomously replicable in bacteria belonging to the genera Escherichia and Gluconobacter. Therefore, for example, manipulation such as insertion of a DNA fragment into the shuttle vector can be perfomed by using Escherichia bacteria, and introduction of a target gene into the Gluconobacter bacteria and the like can be performed by transforming the Gluconobacter bacteria with the obtained recombinant vector. As a cloning site, SacI, BamHI, XbaI, SalI, and PstI sites can used in pSG8, and EcoRI and HindIII sites can used in pSG6.

When Gluconobacter bacteria are transformed by using the shuttle vector of the present invention, a usual transformation method, for example, the electric pulse method and the like can be used. The Gluconobacter bacteria may be preferably exemplified by Gluconobacter oxydans.

Hereinafter, the present invention will be explained further specifically with reference to the following examples.

Gluconobacter oxydans IFO3171 strain was cultured in YPG medium (Yeast Extract 0.5%, Bacto-Peptone 0.3%, glucose 3%, pH 6.5), and cells were harvested by centrifugation. From these cells, a cytoplasmic DNA fraction was extracted by a usual alkali lysis method (Nucleic Acids Res., 7, 1513 (1979)), and separated and purified by agarose gel electrophoresis. As a result, a novel plasmid of about 5.6 kb was found, and designated as pAG5.

A restriction map prepared based on digestion of pAG5 with several restriction enzymes is shown in FIG. 1.

The nucleotide sequence of pAG5 was determined by the dideoxy termination method. The sequencing reaction was performed by using Dye Terminator Cycle Sequencing Kit (produced by ABI) according to the instruction attached to the kit. The electrophoresis was performed by using DNA Sequencer 373 (produced by ABI). The determined nucleotide sequence is shown in SEQ ID NO: 1 in Sequence Listing.

pAG5 was digested with restriction enzyme HindIII. The digestion product and the vector plasmid pUC18 of Escherichia coli (containing ampicillin resistance gene) which was digested by HindIII were mixed, and ligated by DNA ligase. By using the ligation product, Escherichia coli JM109 strain was transformed by the competent cell method. A strain harboring the chimeric plasmid of pAG5 and pUC18 (about 8.3 kb) was selected from the transformants which exhibited ampicillin resistance, and the chimeric plasmid was designated as pSG8.

Further, pAG5 was digested with restriction enzymes HindIII and EcoRI. The digestion product and the vector plasmid pUC18 of Escherichia coli which was digested with HindIII and EcoRI were mixed, and ligated by DNA ligase. By using the ligation product, Escherichia coli JM109 strain was transformed by the competent cell method. A strain harboring the chimeric plasmid of a part of pAG5 and pUC18 (about 6.4 kb) was selected from the transformants which exhibited ampicillin resistance, and the chimeric plasmid was designated as pSG6. The outline of the construction of pSG8 and pSG6 is shown in FIG. 2.

The Escherichia coli JM109 strain harboring pSG8 was given a private number of AJ13485, and it was deposited in the Patent Microorganism Depository, National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry (poatal code 305-8566, 1-3 Higashi 1-chome, Tsukuba-shi, Ibaraki-ken, Japan) on Jul. 21, 1998, and assigned an accession number of FERM P-16903, and transferred from the original deposit to the international deposit based on Budapest Treaty on Jun. 14, 1999, and has been deposited as an accession number of FERM BP-6760. plasmids

The Gluconobacter oxydans ATCC621 strain was cultured in YPG medium. The cells harvested by centrifugation were washed with 10% sucrose solution, resuspended in 10% sucrose solution, and mixed with the chimeric plasmid pSG8 or pSG6 (100 .mu.g/ml). The transformation was performed by the electric pulse method by applying an electric pulse of 1400 V for 7 times using a cell fusion apparatus Shimadzu SSH-10 (produced by Shimadzu). An ampicillin resistant strain was obtained in the both cases using the plasmids pSG8 and pSG6. The plasmids were separated from these strains by the alkali lysis method, and analyzed by agarose gel electrophoresis. As a result, it was confirmed that the trans formants harbored the introduced plasmids. #             SEQUENCE LISTING - -  - - <160> NUMBER OF SEQ ID NOS: 1 - - <210> SEQ ID NO 1 <211> LENGTH: 5648 <212> TYPE: DNA <213> ORGANISM: Gluconobacter oxydans - - <400> SEQUENCE: 1 - - aagctttgca cagatccttg gtctacacgg ctcgtggaac ctcaaaggcc gc - #actgtagc     60 - - cagccaagtg aaagggaggc tcgtctaatg gggacgtttt atgaagagct gg - #caaagctc    120 - - caacatgccc gtttcatcgg aaaaacactg gatgaggtag taaggatcga aa - #agatttct    180 - - gctaaccatc caaccaccat cgcaaggcag gccacaaagg cagaagaaca gc - #aaaccgtc    240 - - gctgatctgg acaaggcgat ggccgcgcac gttcactcaa aaatgcatcc gg - #gtgaaaac    300 - - gagaagcagg catttatccg cctcgtaaac gagcatgatc ctgatgtgtc ag - #cactctac    360 - - agcagacgaa aagcagctat cgcattagcc gacaaaacaa cgggtcgata at - #ggcgcaag    420 - - cgtacacgcc caagggatca agaagagcct ttcagacatt catgacgctc aa - #caagctga    480 - - aatcgtcaaa gcgtctatga ccggagagac cataagcgaa aacgaaccat gg - #ttcgagcc    540 - - atacaaagct catccagaaa tctacttagc tattcgaaca gcacggataa tg - #aggcaaaa    600 - - cgggatggat ggagaatgac tgtgaaaatc cgcactcaag aggacgtggc aa - #agcagctc    660 - - atccagattt acagcgatgc acgagaaggc agaattacac ccaaggccgc cg - #atcggctc    720 - - tcacgggttc tgcatcgtct caaacctctg ctccctctga atgacttcgt cg - #ctgattta    780 - - gcccaattcg gaaactgaaa tggccagacc acggattacc gttgatgaag aa - #gcccttga    840 - - gcatctgatc ggtcttggcg tctcaatcgg tctggcagcc gacattatgg aa - #gtgagcga    900 - - aagcacgatt gcacggcacc tgaagcgcaa tccagaagct cacaaacgga tg - #acggcggc    960 - - gagaacacgg gctcagaaca cgactgattg cggaaatggt aaggcgtggg ct - #caaaagca   1020 - - gcgacagact gctcctggca tctgtagaac gattggccgg gctcaaatct ca - #tgctcttg   1080 - - aaatcagcgg tccgaatggt ggtcctatcg ggcttcacca taacgctgac gt - #cagctcgg   1140 - - aaattatgac agaagccagc gagctactga aacaaatcca agaagcagct cg - #taatcggg   1200 - - atggagatcc aagctctacc gaagtagaat aagtcttctc ctgtttccaa cg - #ataggaag   1260 - - cgcgtcggtt catcccgacg cgttttctat ttctggacca tcaacacagc ca - #aggcgcat   1320 - - caaagatgcg ggctacgccg ctcccgcgct gcgctcgccc ttggcatgac gg - #gtccgtgc   1380 - - aaacccgttt gggtatctgc tcaagggcca atgagtggac gggaaggcca tt - #cctcacat   1440 - - ctgaagagta gagctgcgag aaatcccgta tgcctttctg caatacgcca cg - #agcgtgat   1500 - - ggtcaagatc cttggggaga ttgtagcagg ttttctcacg ttcatatctg tc - #cagataga   1560 - - tgccctgaaa tttgagggca tcttctccaa cgccaccgca tctttgcgtt cg - #catcgcgc   1620 - - cagtgaacga actcaaaatt gagggcgtca gtcgcttgca agcagacgcc ct - #agaataaa   1680 - - acagccaatc gatggtcgct tggttaagtt ttaggagaac gatcatgggt aa - #aaacccag   1740 - - acgatcagaa gatgccagac ccctacttct ttttgttgtt gctaatcttt ga - #tgtggtga   1800 - - tggtcagtgc tgacctgatc ggactagcgc gtctctgctg ataaaaatca ga - #agctgaag   1860 - - atgacctgca cttccttaat ggaggttcag gtcatcacca agcgcggaaa gg - #cgatgcgg   1920 - - gaattcccgc atcggtcagt aagcccaccc attaagactt cattttcctt cc - #aaaccata   1980 - - aggcaagaaa tatcatagaa gcagtaacga tttgctcgat ggtactgaga ta - #atagcctg   2040 - - acaaaacggc ctcctaaaat gaaggatggc cgcctcttgt cttgcatcgg ct - #cgaaagat   2100 - - gcacttacaa cccaagaacg tcatatggtt ctccccattt atgactggcg gc - #cgattatg   2160 - - gacaatcggt ccaattcaag ggctcgggtg ttacagcact cgagccctta ca - #aatgcatt   2220 - - tccacatcag aagcgcactc tgcaagcgaa ctcttagctt gcaaaaagca ac - #gagctgtg   2280 - - aattttgaaa tttagaacaa atctctgagt acttatccac acccgaaaaa cc - #aattttac   2340 - - ccatagacaa cggtaagtac tgaagcagtt agccttttta ggaagaaaga at - #accctcaa   2400 - - aaaataatca cgaaacttga cgctaaattg gtcaatatta gagggtcagg ta - #ccagaaaa   2460 - - cattcaatca ggcggtgaac gctgcataat ccgctcccag atcaaacgat aa - #acgtcaca   2520 - - ccactcaatc ccctcggtta tcgccaactt tttagtgatg cgaatgatcc ag - #gcatgatc   2580 - - gaaaacagga tgattggcag cccgcttcca aacagcaacc ggaagaagcc ca - #acaggctt   2640 - - ttcgtcctgc gcttcaagct ccggctcttg ctcgtctgca atgtcttcga ag - #tccagatc   2700 - - taagatcccc ttcaatcggg gaccaaccac aagcagacgt tgacctgaca gg - #gcagaaac   2760 - - tgcttcggcg tacttctggc cagcaagtcg gtcaccttca gcggccaacg ca - #agcaactc   2820 - - aggaacattc aggcgattag ggcgcttccc ggttttcttc catccggccg cc - #atctcaga   2880 - - agccattccc caactgcgaa gatctgcgac cccataatca gacaagcctt tg - #tcttcaga   2940 - - taccggaaca accttctgcc ctgatccaac ggcgatatga ccagccttgg cc - #aacaggtc   3000 - - gatccagcga cctgtgagcg actggcccgc actaacggcc gcctttgcgc cg - #tcccggtg   3060 - - aataacaatc gcatggacat gcagatgcca gcccgtccta gcgccccaag tc - #acctcaaa   3120 - - gacccggata aagccgacca gaccgtccct gagcagccgg ttccacaagc ca - #ccacgctg   3180 - - catcgcggaa atagccttag tctgaaccgt ccgcatgttt gacaggcgag tg - #tttcggtc   3240 - - atgccgcata gtccatgtgg cgaatgcagc gccgtatcca ttggcatgaa cc - #gctttgag   3300 - - gaccgcacca acccgggcag acacatcaga tgcccgtaga ggcgcacagt ga - #gggcaacg   3360 - - agcagagccg caatgcgtga cgccatccac ggccaaccgc gttgatccat cc - #cgagcagc   3420 - - aacagggcgg agagaaatgt gggcagtatc tttgccaggc aaaccacaag cg - #cggatcga   3480 - - acatctcacg tcatgatcgt gcaagacctt cctagaagcc ttggataacc gc - #catttttg   3540 - - ctcgtctttt gcctctgggg gggtaaaccg atttcctctg ttatcaaggg gc - #tcagattt   3600 - - ggtgtccgga gctttacccg acagagcatc caaaccggca aaatcctgcc ct - #gacgcttt   3660 - - cgaagtaatc cgagcattct tggaagcgct cgacgcagaa aaatgacgtg ca - #tttggccc   3720 - - cttgcgggat acctcatgca gattttttat ctttccacat tgaggatttt cg - #ggctgaaa   3780 - - accgctattt tttaggggtt ctttaagcaa aatccccgcc aaacatggcg gt - #ctggtgtt   3840 - - gaaatcgcgc ttcaattcct gatatggaaa aagcgcggat cggggtatgc ga - #aaacatag   3900 - - cctgttctaa gttctgggcc tatttcgggc tttcgccaag ttgcaaaccg ag - #atcagccc   3960 - - tgatccgtgc caccagacct aacgtagctt ctcaccggta ggcaagccct cc - #cgacaatc   4020 - - tctggtattc caaaccagtg aagcgcgtct ctgcatgacc ttcttctcat cg - #tccctaat   4080 - - gatgaaaatg cctttcccgt cttagggtct gcgccagctt gcaccgacca ac - #ccaaactt   4140 - - aggttcgttc atcacaaagg aaatcaacgt cacatctcga acgtaataga ct - #gcctatcc   4200 - - taggtatttt cctgctctct aacgatcact cgccctgatc gtgtccgaaa ga - #gcctttgg   4260 - - tctgatcatt tgtctgaccg cgcttcacgt cctgcgctac acgattgacc aa - #ctggaacg   4320 - - cagttttctg cacatgatca ggaacagtca gaccggcaga ggccatccgc ac - #tacaagat   4380 - - caactgcttg agtggcgtcg gtaagactga cagggcttac ttgtctgaca gc - #gacctttt   4440 - - tacccgcgtt cctgtctgcc ttgatcttct cgcggatggc agaggcgatc ca - #ttctccaa   4500 - - caccaacacc agcagtcttg gcatgtgaga cagcagcttg cttcacgtct ga - #aggaactc   4560 - - cccggatgct ccaaggtgtt gcgtcagtct gatttccggt tcatgtcata ct - #cctatcag   4620 - - cttctgtagt caggaaaagc caaagtgtct gccccacaag ggatacgtct aa - #caaacaga   4680 - - cggaaatgta gacaagagcg tcaatctgaa tgactgccac agggcttatg gc - #ggggatgc   4740 - - atcaaagcgc cctggcattt agatggcgca caaggagacc aaagcgcttg tg - #atcgagtt   4800 - - ggagcctcgg gaaattcccc taccaccctt aacagaagct ctgatcaggt tt - #tgctcggg   4860 - - aaaaaagacg tagggacaag acaccgtcaa aaccattttg tgcgggtttt ct - #catacgct   4920 - - ctgaagaaac aaagagaatt ttcgcatgtc tttggaaaga cgcgattaat aa - #tccagata   4980 - - caaacaaata atgcaaaaat gttctaaaat ataagaacaa ttctagtctt ct - #gaaatttc   5040 - - accaaattga agttcataga tcaaaaactt tgatatctat ctaattaaac aa - #tagaatat   5100 - - ggctattatc atcacacatg gatctgatca tgacctatgg cggcactcat gc - #caatgcca   5160 - - gtcagcgcac cgggaccgaa gcgtgatctt gccgacgcga tcactcaacg gg - #acacactc   5220 - - acaaaacggc tgaaagctct tcggaccaac attcaggcat gccgtggtgc ag - #gccgagat   5280 - - atcccggcca atctggcatt cgatcttctg caaaccgagc gttctgtcga ag - #ccaaggaa   5340 - - aaagaactgg caggtctgga agtcatctgc cgggatcatc tcaagcaacg at - #ccgaagaa   5400 - - gaactgaagc agaaagagaa ggctgagatt gctcaccggg aaaccgtagc ag - #cgtactca   5460 - - actgaagtcc tgacggctgc caagcagact gatgacgctc tttcggcttt ga - #tcacggcc   5520 - - ttcacctcat tgaagactgc aagccagagc ctaagcctac acaacggcat ca - #cgatcgat   5580 - - ggatgggcta acaacccgga aagctggctc atggaagcca tgggcaccat ga - #acacatca   5640 - - gacggaaa                - #                  - # - #        5648 __________________________________________________________________________

## Claims

1. An isolated plasmid autonomously replicable in a bacterium belonging to the genus Gluconobacter which is the endogenous plasmid of Gluconobacter oxydans IFO3171 strain and has a size of about 5.6 kb.

2. The isolated plasmid of claim 1, which has the nucleotide sequence of SEQ ID NO: 1.

3. The isolated plasmid of claim 1, which is autonomously replicable in a bacterium belonging to the genus Gluconobacter and a bacterium belonging to the genus Escherichia.

4. The isolated plasmid of claim 1, which further comprises a marker gene.

5. The isolated plasmid of claim 4, wherein the marker gene is a drug resistance gene.

6. The isolated plasmid of claim 1, which further comprises a multiple cloning site, wherein said multiple cloning site comprises a restriction site for at least one restriction enzyme selected from the group consisting of EcoRI, HindIII, SacI, BamHI, XbaI, SalI and PstI.

7. A plasmid comprising a Gluconobacter oxydans replication region which is obtained by digesting the endogenous plasmid of claim 1 with one or more restriction enzymes to obtain a fragment of the endogenous plasmid, coil to obtain a chimeric plasmid, determining if the chimeric plasmid is harbored by the transformant, wherein if the chimeric plasmid is harbored by the transformant, it is a plasmid comprising a Gluconobacter oxydans replication region.

8. The plasmid comprising a Gluconobacter oxydans replication region of claim 7, which is autonomously replicable in a bacterium belonging to the genus Gluconobacter and a bacterium belonging to the genus Escherichia.

9. The plasmid comprising a Gluconobacter oxydans replication region of claim 7, wherein said fragment is responsible for autonomous replication in a bacterium belonging to the genus Gluconobacter.

10. The plasmid comprising a Gluconobacter oxydans replication region of claim 7, wherein said restriction enzyme is selected from the group consisting of HindIII, EcoRI, XhoI and SphI.

11. The plasmid comprising a Gluconobacter oxydans replication region of claim 7, which further comprises a marker gene.

12. The plasmid of claim 11, wherein the marker gene is a drug resistance gene.

13. The plasmid of claim 12, which is pSG8 or pSG6.

14. The plasmid comprising a Gluconobacter oxydans replication region of claim 7, which further comprises a multiple cloning site, wherein said multiple cloning site comprises a restriction site for at least one restriction enzyme selected from the group consisting of EcoRI, HindIII, SacI, BamHI, XbaI, SalI and PstI.

15. An isolated plasmid comprising at least one restriction enzyme fragment of SEQ ID NO: 1.

16. The plasmid of claim 15, which is autonomously replicable in a bacterium belonging to the genus Gluconobacter and a bacterium belonging to the genus Escherichia.

17. The plasmid of claim 15, wherein said restriction enzyme fragment is responsible for autonomous replication in a bacterium belonging to the genus Gluconobacter.

18. The plasmid of claim 15, wherein said restriction enzyme fragment is generated by digestion of SEQ ID NO: 1 with at least one enzyme selected from the group consisting of HindIII, EcoRI, XhoI and SphI.

19. The plasmid of claim 15, which further comprises a marker gene.

20. The plasmid of claim 19, wherein the marker gene is a drug resistance gene.

21. The plasmid of claim 15, wherein the plasmid further comprises a multiple cloning site, wherein said multiple cloning site comprises a restriction site for at least one restriction enzyme selected from the group consisting of EcoRI, HindIII, SacI, BamHI, XbaI, SalI and PstI.